ТОО "САРОН ОПТИКА"
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Risks
0/18Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Procurement signals
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses and permits
Summary
Министерство юстиции РКActivities
86909 Прочая деятельность в области здравоохранения, не включенная в другие группировки
Прочая деятельность в области здравоохранения, не включенная в другие группировки
Contacts
Change history
Financial statements
PremiumPublic contracts
What it sells and where
Samruk-Kazyna procurement
Tender bids
Procurement as a customer
Assets
Bank accounts
Leadership
1- НИ
Нуруллина Ильхамия Фаркатовна
Director
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Company networks
PremiumSimilar companies
Media mentions
Company summary
Active legal entity ТОО "САРОН ОПТИКА" (BIN 050940021211), Almaty. Registered in 2005, 21 years on the market. Main activity: healthcare. Size: small enterprise, staff of up to 5. Open registry checks show no risk indicators for «САРОН ОПТИКА». The latest change to registration data: change of main activity (May 1, 2024). Founders: 2. The registry names Нуруллина Ильхамия Фаркатовна as director. Registry data current as of June 11, 2026.
Data sources and disclaimer
Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.